{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:44:39Z","timestamp":1777927479072,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jbspin.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:03:38Z","timestamp":1448269418000},"page":"341-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Certolizumab treatment during late pregnancy in patients with rheumatic diseases: Low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients"],"prefix":"10.1016","volume":"83","author":[{"given":"Frauke","family":"F\u00f6rger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Zbinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Villiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.07.004_bib0070","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/art.24003","article-title":"Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study","volume":"59","author":"de Man","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0075","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.1780260915","article-title":"A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis","volume":"26","author":"Ostensen","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0080","first-page":"w13644","article-title":"Pregnancy mediated improvement of rheumatoid arthritis","volume":"142","author":"Forger","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0085","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study","volume":"60","author":"de Man","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0090","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3748\/wjg.v19.i17.2591","article-title":"Tumor necrosis factor-alpha inhibitor therapy and fetal risk: a systematic literature review","volume":"19","author":"Marchioni","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0100","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0105","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coph.2013.03.004","article-title":"How safe are anti-rheumatic drugs during pregnancy?","volume":"13","author":"Ostensen","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0110","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/ard.2003.016881","article-title":"A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments","volume":"63","author":"Ostensen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0115","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.30210","article-title":"Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth","volume":"63","author":"Wallenius","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0120","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.amjmed.2014.06.012","article-title":"The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trials","volume":"127","author":"Michaud","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2008.089276","article-title":"Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry","volume":"69","author":"Greenberg","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.07.004_bib0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/QCO.0b013e328360dc31","article-title":"Genitourinary pathogens and pre-term birth","volume":"26","author":"Cunnington","year":"2013","journal-title":"Curr Opin Infect Dis"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15002171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15002171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T09:57:00Z","timestamp":1537178220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X15002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1297319X15002171"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.07.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Certolizumab treatment during late pregnancy in patients with rheumatic diseases: Low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}